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Background: In this study, we aimed to 
examine demographic and endoscopic 
features of patients with GI bleeding to 
determine the factors a!ecting 30-day 
mortality. Method: Patient’s demographic 
features, laboratory outcomes, comor-
bidities, drug use, endoscopy outcomes, 
Glasgow-Blatchford scores, and mortality 
status were examined. "e factors a!ect-
ing 30-day mortality were investigated. 
Results: "e mean age of the patients was 
58.2±17.4 years, and 72.1% were male pa-
tients. 30-day mortality rate was found to 
be 14.4%. "e mean age of patients who 
died was high (p<0.05). "e incidence 
of mortality was high in the presence of 
comorbidity, malignancy, and cirrho-
sis (p<0.05). Systolic blood pressure was 
low in the patients who died (p<0.05). 
No signi#cant correlation was found be-
tween mortality and gender, symptoms, 
predisposing factors, lesion type and For-
rest score, diastolic blood pressure and 
heart rate (p>0.05). Urea, neutrophils, 
red blood cell distribution width / platelet 
ratio, neutrophil / lymphocyte ratio and 
RDW levels were high, and hemoglobin 
level was signi#cantly low in patients with 
a mortal progression (p<0.05). No signi#-
cant correlation was found between mor-
tality, and platelet and lymphocyte levels 
(p>0.05). Glasgow-Blatchford score was 
signi#cantly higher in patients who died 
(p<0.05). Conclusion: Many factors a!ect 
30-day mortality in GI bleeding. It should 
be remembered that follow-up of patients 
with an advanced age who have comorbid-
ity and impaired hemodynamics should be 
kept for long, and that these patients are at 
a high risk for mortality.
According to our results, NLR and RDW 
are independent factors that determine the 
30-day mortality in upper GI bleeding.
Keywords: emergency, mortality, NLR, 
RDW
INTRODUCTION
Patients presenting to emergency depart-
ments with upper Gastrointestinal (GI) 
bleeding constitute a signi#cant percent-
age of all emergency department admis-
sions. Upper GI bleeding accounts for 
80–85% of all cases of GI bleeding with an 
incidence of 50–150 per 100,000 persons 
(1-3). Notably, 80% of patients with GI 
bleeding recover spontaneously without 
any intervention, and 20% of patients re-
ceive medical or surgical treatment (2,3). 
Despite advances in endoscopic and medi-
cal therapy, the mortality rate associated 
with this condition is 2–5% (4-6).
Patients with massive upper GI bleeding 
may present to emergency departments 
with shock, as well as with symptomatic 
anemiasecondary to chronic blood loss. 
Given the high mortality rate associated 
with GI bleeding, rapid diagnosis and 
prompt treatment are important in such 
cases (7).
Although several factors are known to af-
fect mortality rates in patients with upper 
GI bleeding, poor endoscopic outcomes 
and the severity of bleeding are the most 
important risk factors associated with 
mortality. "e most important prognostic 
factor remains controversial (1).
We investigated the factors independently 
a!ecting 30-day mortality rates in patients 
with GI bleeding.
MATERIALS AND METHODS
Following approval from the Local Eth-
ics Committee of ŞişliEtfal Training and 
Research Hospital, we retrospectively in-
vestigated patients who presented to the 
emergency department.
Patient details were obtained from the 
electronic medical record system of the 
hospital. We contacted patients' relatives in 
cases where the out-of-hospital mortality 
status of patients was unknown to con#rm 
if those patients had survived and to obtain 
mortality details in the deceased.
Patient demographics, laboratory test re-
sults, comorbidities, drug use, endoscopy 
outcomes, Glasgow-Blatchford scores and 
mortality status were examined and fac-
tors a!ecting 30-day mortality rates were 
investigated.
A&er screening using the information 
processing system of the hospital, we in-
cluded the following patients in the study: 
patients aged >18 years who presented 
with melena, hematemesis or hematoche-
zia during physical examination in whom 
bleeding was con#rmed to be GI bleeding 
and patients with GI bleeding de#nitively 
diagnosed by endoscopic or colonoscopic 
examination. "e following patients were 
excluded from the study: patients aged <18 
years, those with suspected GI bleeding 
and patients in whom data pertaining to 
history, physical examination and labora-
tory tests were missing.
"e patients were divided into two groups 
as those who deceased within 30 days af-
ter gastrointestinal bleeding (Group2) and 
those who survived (Group 1).
Statistical Analysis
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Data were analyzed using the SPSS 22.0 
so&ware. 
Parametric data were expressed as mean± 
standard deviation. Non-parametric data 
were expressed as medians and inter-
quartile ranges, and qualitative data were 
expressed as frequencies and percentages. 
Normality of variables was evaluated using 
the Kolmogorov-Smirnov test. "e Stu-
dent t-test was used to analyze parametric 
data, and the Mann-Whitney U test was 
used to analyse non-parametric data. "e 
Chi-square and the Fischer exact test were 
used to analyze qualitative data. Multivari-
ate logistic regression analysis was used to 
determine independent factors a!ecting 
mortality rates. Receiver operating char-
acteristic curve (ROC) analysis was per-
formed to determine the e!ectiveness of 
detecting mortality rates for neutrophil/
lymphocyte ratio (NLR) and the red blood 
cell distribution width (RDW). A p value 
<0.05 was considered statistically signi#-
cant.
RESULTS
"is study included 111 patients. Nota-
bly,16 patients (14.4%) died within 30 days 
of developing upper GI bleeding. Mean 
age of the patients was 58.2±17.4 years and 
72.1% were men (Table 1). 
"e mean age of deceased patients was sig-
ni#cantly high (p<0.05). No signi#cant cor-
relation was observed between mortality 
rates and sex (Table 1). "e most common 
#nding was melena (73%); however, no sig-
ni#cant correlation was observed between 
mortality rates and all #ndings (Table2) 
(p>0.05).
Among all patients included in the study, 
60.4% reported comorbidities. "e mor-
tality rate was high in patients with co-
morbidities, malignancy, and cirrhosis 
(p<0.05) (Table 1). Predisposing factors 
were observed in 79.3% of patients; how-
ever, no signi#cant correlation was ob-
served between predisposing factors and 
mortality rates (p>0.05) (Table 1). Systolic 
blood pressure was signi#cantly lower in 
deceased patients (p<0.05). No signi#cant 
correlation was observed between mortal-
ity rates and diastolic blood pressure and 
heart rate (p>0.05). Serum blood urea ni-
trogen (BUN) and neutrophil levels, RDW/
to platelet (PLT) ratio, NLR, and RDW 
levels were high, and hemoglobin(HGB) 
level was signi#cantly low in deceased 
patients(p<0.05). No signi#cant correlation 
was observed between mortality rates and 
serum PLT and lymphocyte levels (p>0.05) 
(Table 3).
"e median Glasgow-Blatchford score was 
14 (6) in deceased patients and 11 (7) in 
surviving patients. "e median Glasgow-
Blatchford score was signi#cantly higher in 
deceased patients(p<0.05) "e most com-
mon lesions observed in patients were duo-
denal and/or peptic ulcers (95.5%); howev-
er, no signi#cant correlation was observed 
between the type of lesion and mortality 
rates (p>0.05). No signi#cant correlation 
was observed between mortality rates and 
the Forrest classi#cation (p>0.05) (Table 4).































































Figure 1. ROC analysis for NLR
List abbreviations and their meaning 
under the table
NLR:neutrophil/lymphocyte ratio
Figure 2. ROC analysis for RDW
List abbreviations and their meaning
RDW: red blood cell distribution width
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Table 2.Complaint and 'nding of patients at admission according to groups

























































Table 3. Vital sign and labratory results of patient according to groups
Variable Survival (n:95) Deceased (n: 16) P value
Vital sign Systolic blood pressure, Median (IQR) (mmHg)
Diastolic blood pressure, Median (IQR) (mmHg)










Labratory results UREA, Median (IQR) (mg/dL)
HGB, Mean±SD (gr/dl)
Platelet, Median (IQR) (x103/mm3)
RDW, Median (IQR)




















IQR: Interquartile range, HGB: Heamoglobin, RDW: red blood cell distribution width
Table 4. Endoscopy results and Forest clasi'cation according to groups.
Categorical Survival, n(%) Decease,  n(%) p







































Table 5. Logistic Regression Analysis of the Factors A(ecting Mortality 
Univariate Model Multivariate Model
 OR 95% CI  p OR 95% CI p
Age 3.18 1.77 - 5.69 0.000 2.09 1.05 - 4.15 0.035
Comorbidity 29.02 3.77 - 223.63 0.001 9.33 1.06 - 82.20 0.044
Aspirin Use 2.93 1.14 - 7.53 0.025
BUN   70 3.09 1.28 - 7.48 0.012
RDW 1.41 1.16 - 1.72 0.000 1.30 1.05 - 1.61 0.017
Lymphocytes 0.56 0.35 - 0.89 0.014
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Multivariate logistic regression analysis 
showed that age, comorbidities and RDW 
and NLR values were independently and 
signi#cantly correlated with mortality 
rates (p<0.05)(Table 5).
ROC analysis was performed to determine 
the predictive value of NLR (Figure 1) and 
RDW (Figure 2) for mortality.
NLR values were signi#cantly e!ective in 
distinguishing between deceased patients 
and survivors (area under the curve 0.717 
[0.606–0.829]). A cut-o! value of 3 was 
observed to be the highest cut-o! value 
for NLR, (area under the curve) in distin-
guishing between deceased patients and 
survivors. Using this cut-o! value, sen-
sitivity was 71.4%, speci#city was 37.7%, 
positive predictive value was 60.2% and 
negative predictive value was 86.2%. RDW 
values were signi#cantly e!ective in dis-
tinguishing between deceased patients 
and survivors (Area under the curve 0.726 
[0.609–0.8243]). A cut-o! value of 14.5 
was observed to be the highest cut-o! val-
ue of RDW (area under the curve) in dis-
tinguishing between deceased patients and 
survivors. Using this cut-o! value, sen-
sitivity was 67.9%, speci#city was 74.7%, 
positive predictive value was 47.5% and 
negative predictive value was 87.3%. 
DISCUSSION
Patients presenting with upper GI bleed-
ing show high mortality rates and 80% of 
these deaths occur from bleeding-related 
causes. Other leading causes of mortality 
include terminal malignancy, multiorgan 
failure and cardiopulmonary decompensa-
tion (8, 9). 
In our study, age, comorbidities, as well as 
NLR and RDW values were observed to be 
independent risk factors a!ecting 30-day 
mortality rates. Neutrophils and lympho-
cytes increase secondary to GI bleeding-
induced in'ammationGI. Kandemir et al. 
reported that leukocytes and NLR were 
e!ective predictors of mortality in patients 
with GI bleeding (10). Peng et al. reported 
the prognostic e(cacy of NLR in patients 
with GI bleeding (11). In our study, the 
neutrophil count was high, the lympho-
cyte count was low, and the NLR ratio was 
high in deceased patients. In our view, the 
high neutrophil rate and NLR were asso-
ciated with more severe in'ammation in 
deceased patients.
Isik et al. reported that RDW was increased 
in patients with GI bleeding and that RDW 
values were higher in deceased patients 
than in survivors. "is observation was 
attributed to increased stress in patients 
(12). Ozdemir et al. reported that among 
patients followedup in the intensive care 
unit, RDW was lower in patients who were 
discharged and higher in deceased pa-
tients (13). In our study, RDW was higher, 
the PLT count was similar and the RDW/
PLT ratio was higher in deceased patients, 
which can be attributed to the fact that 
RDW was elevated secondary to increased 
stress.
A study reported by Christensen et al. 
showed that the 30-day mortality rate was 
10.8% in patients with bleeding peptic ul-
cers (14). "e 30-day mortality rate in pa-
tients with upper GI bleeding was 4.5% in 
a study reported by Marmo et al. GI (15), 
6.2% in a study reported by Sung et al. (8), 
8.7% in a study reported by Lee et al. (16), 
and 31.1% in a study reported by Crooks et 
al. (17). In our study, the 30-day mortality 
rate was 14.4% (higher than rates reported 
in the literature), which could be attrib-
uted to several factors ranging from social 
characteristics of patients to the treatment 
administered. Additionally, it might be 
related to the fact that patients with mild 
disease were not referred to our hospital (a 
tertiary center).
Previous studies have reported that the in-
cidence of upper GI bleeding is higher in 
elderly patients and it is associated with 
a higher mortality rate in this age group 
(15, 18). A study reported by Sung et al. 
investigated mortality patterns in those 
with upper GIS bleeding over a 30-day pe-
riod, and reported that deceased patients 
were older (8). Christensen et al. reported 
that age was a signi#cant and independ-
ent factor associated with 30-day mortality 
rates in patients with complicated peptic 
ulcers(ulcers associated with bleeding and/
or perforation) (14). In our study, the mean 
age of patients was 58.2±17.3 years. We 
observed that the mean age was higher in 
deceased patients, and that age was inde-
pendantly associated with mortality rates, 
which could be attributed to increased vas-
cular fragility, decreased cardiac reserve, 
increased comorbidities and drug use in 
elderly patients.
A few studies have reported that upper GI 
bleeding is more common in men (15, 18). 
However, Marmo et al. (15) and Sung et al. 
(8) reported no correlation between the 
30-day mortality rates and sex. Our study 
results were consistent with the literature 
in that upper GIS bleeding was observed 
more commonly in men, although no sig-
ni#cant correlation was observed between 
mortality rates and sex. In our view, upper 
GI bleeding occurs more commonly in 
men because the use of substances such as 
tobacco and alcohol, as well as antiplate-
let and anticoagulants drugs is greater in 
men secondary to higher occurrence of 
ischemic events and a more stressful life. 
However, a patient’s clinical condition af-
fects mortality, and a patient’s sex is not 
relevant in this context.
Previous studies have reported that pa-
tients most commonly present with mele-
na, although no correlation was observed 
between melena and mortality rates (19, 
20). Lanas et al. reported that patients 
with hematemesis were at a higher risk of 
death (21). In our study, the most common 
symptom observed in patients was melena; 
however, melena was not correlated with 
mortality rates. In our opinion, melena was 
the most common symptom in our study 
because even small quantities of bleed-
ing (50 mL) cause melena. A small quan-
tity or slow chronic bleeding from a lower 
site in the GI can cause melena. However, 
we reckon that symptom severity and the 
quantity of bleeding a!ect mortality rates 
rather than the occurrence of bleeding.
A few studies have reported that comor-
bidities and the administration of certain 
drugs increase the incidence of GI (19, 22, 
23). Siddique et al. reported that comor-
bidities such as stroke and pneumonia 
were not associated with readmission and 
mortality; however, cirrhosis and malig-
nancy, among other such conditions, in-
crease the incidence of re-bleeding (24). 
Sung et al. reported high 30-day mortal-
ity rates in patients with multiple comor-
NLR 1.18 1.07 - 1.31 0.001 1.13 1,00 - 1.28 0.041
RDW/Platelet 728.77 1.97 - >1000 0.029
Blatchford Score 1.17 1.05 - 1.31 0.006
IQR: Interquartile range, HGB: Heamoglobin, RDW: red blood cell distribution width, NLR:neutrophil/lymphocyte ratio
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bidities and predisposing factors (use of 
nonsteroidal anti-in'ammatory drugs 
[NSAIDs] and/or aspirin)(8). Marmo et al. 
reported a higher occurrence of comorbid-
ities in patients who died within 30 days of 
developing upper GI bleeding (15). Lanas 
et al. reported that the mortality risk was 
lower in patients who used warfarin and 
NSAIDs (21). In our study, mortality rate 
was high in patients with comorbidities 
and in those with malignancy and cirrho-
sis; however, predisposing factors did not 
a!ect mortality rates. "e 30-day mortal-
ity rate might be higher in patients with 
cirrhosis and malignancies because these 
conditions precipitate bleeding. Cirrho-
sis causes bleeding secondary to variceal 
bleeding and reduction in serum levels 
of coagulation factors is observed in both 
malignancy and cirrhosis. We concluded 
that antiplatelet and anticoagulant agents 
did not a!ect the 30-day mortality because 
their doses were adjusted in this study.
Reportedly, hemodynamic instability is a 
common factor associated with upper GI 
bleeding-induced mortality (21, 25, 26). 
Marmo et al. reported that heart rate was 
higher and blood pressure was lower at 
the time of admission to the hospital in 
patients who died within 30 days of de-
veloping upper GI bleeding (15). In our 
study, we observed signi#cant hypotension 
and higher pulse rate in deceased patients, 
although this di!erence was statistically 
non-signi#cant. İt is known that blood 
pressure reduction is proportionate to 
bleeding and tachycardia is known to oc-
cur in patients with severe bleeding. "is 
non-signi#cant result might be attributed 
to a small number of deceased patients and 
the use of drugs causing bradycardia.
Onder et al. reported decreased serum 
HGB levels in deceased patients with up-
per GI (18). Marmo et al. reported lower 
serum HGB levels in patients who died 
within 30 days (15). Increased BUN val-
ues observed in patients with GI bleed-
ing are caused by increased re-absorption 
and hypovolemia following conversion of 
blood proteins to urea by intestinal bacte-
ria (27). Tomizawa et al. observed that pa-
tients with serum BUN values>21 mg/dL 
showed a higher incidence of GI bleeding 
(28). In our study, serum HGB and BUN 
levels were signi#cantly higher in deceased 
patients. "ese results can be explained by 
the fact that bleeding is an important fac-
tor that alters patients’ hemodynamics and 
is associated with mortality. It is reasonable 
to deduce that hypovolemic shock led to 
higher BUN values in patients with more 
severe bleeding.
 
Sung et al. reported a correlation between 
the 30-day mortality rates and lesion lo-
calization (8). Crooks et al. reported simi-
lar mortality rates regardless of lesion lo-
calization (17). In our study, we could not 
identify a correlation between mortality 
rates and lesion localization. In our opin-
ion, although the quantity of bleeding is 
a!ected by several factors including vas-
cularization in the lower parts of lesions, 
lesions in speci#c locations (esophageal 
varices), and lesion invasion, these fac-
tors did not a!ect mortality rates because 
bleeding ceased a&er the administration 
of treatment. Additionally, investigating a 
small number of patients with lesions in 
only a few locations might lead to inaccu-
rate and non-signi#cant results.
Marmo et al. reported that ulcer diameter 
was wider in patients who died within 30 
days (15). Sung et al. reported that the 
mortality rate was higher in patients with 
active bleeding ulcers (8). Sey et al. report-
ed mortality rates of 7% in patients with 
esophageal and gastric lesions and 10% in 
those with duodenal bleeding (4). In our 
study, most patients were classi#ed into 
grade 3 based on the Forrest classi#cation 
and no correlation was observed between 
mortality rates and the Forrest classi#ca-
tion. However, deceased patients showed 
a higher Glasgow-Blatchford score. We 
consider quantity of bleeding to be a pri-
mary determinant of mortality rather than 
the features of the bleeding lesion. "ere-
fore, theGlasgow-Blatchford score (which 
predicts the need for hemodynamic inter-
vention) is more useful than the Forrest 
score. "e lack of a signi#cant correlation 
between mortality rates and the Forrest 
score could be attributed to the fact that 
active bleeding causes severe and acute 
blood loss, whereas slow chronic bleeding 
causes severe losses over time. Addition-
ally, a small number of patients with stage 
1 and stage 2 disease who were investigated 
might have led to this result.
CONCLUSION
In conclusion, several factors a!ect 30-day 
mortality rates in patients with GI bleed-
ing. Clinicians should be aware that elderly 
patients, those with comorbidities and im-
paired hemodynamics require careful and 
long-term follow-up and that these pa-
tients are at a high risk for mortality.
LIMITATIONS
Following are the limitations of this study: 
(1) "is was a small-scale study. (2) Mor-
tality was attributed only to GI bleeding. 
(3) Comorbidities and drugs used were 
evaluated based only on the patients’ med-
ical history without analysing documented 
data regarding the duration of disease and 
drug use. (4) Although eradication of Heli-
cobacter pylori decreases bleeding in pa-
tients with peptic ulcer, we could not ana-
lyse the presence of this organism in our 
study population.
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